Back to News
Market Impact: 0.4
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
Source: globenewswire.com
Company FundamentalsManagement & GovernanceLegal & LitigationHealthcare & Biotech
Stryker shares fell $26.70, or 8.8%, on September 8 after its CFO disclosed that a manufacturing issue previously believed to be resolved remains ongoing. The disclosure raises operational-execution and potential legal-risk concerns for the medical-device company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.55
Ticker Sentiment
SYK-0.85
More News
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months
- How Meta took the lead in the race for the post-smartphone world
- SoftBank shares jump over 7% after $11.1 billion bond issuance to fund OpenAI bet
- Australia says OpenAI agent hacked Medicare portal
- US aviation sanctions disrupt Iran flights, push travellers overland
- Meta Debuts $349 Camera-Free Ray-Bans and Brings Muse to Glasses